statistiche per MILLA, Paola

Distribuzione geografica

Continente	#
EU - Europa	6157
NA - Nord America	2702
AS - Asia	1283
AF - Africa	32
Continente sconosciuto - Info sul continente non disponibili	16
SA - Sud America	14
OC - Oceania	7
Totale	10211

Salva come PNG Salva come JPEG

Nazione	#
IT - Italia	4047
US - Stati Uniti d'America	2648
CN - Cina	743
FR - Francia	471
SE - Svezia	352
DE - Germania	273
FI - Finlandia	261
KR - Corea	255
UA - Ucraina	208
PL - Polonia	154
GB - Regno Unito	129
JP - Giappone	106
VN - Vietnam	87
AT - Austria	77
CA - Canada	48
CH - Svizzera	40
ES - Italia	32
IN - India	28
SN - Senegal	27
IE - Irlanda	24
NL - Olanda	21
RO - Romania	18
TR - Turchia	15
IL - Israele	14
EU - Europa	13
RU - Federazione Russa	11
BE - Belgio	9
BR - Brasile	9
IR - Iran	7
AU - Australia	6
DK - Danimarca	6
MX - Messico	5
CO - Colombia	4
ID - Indonesia	4
LT - Lituania	4
PT - Portogallo	4
TW - Taiwan	4
UZ - Uzbekistan	4
CZ - Repubblica Ceca	3
PH - Filippine	3
TH - Thailandia	3
AE - Emirati Arabi Uniti	2
AP - ???statistics.table.value.countryCode.AP???	2
EG - Egitto	2
GR - Grecia	2
JO - Giordania	2
SM - San Marino	2
ZA - Sudafrica	2
A2 - ???statistics.table.value.countryCode.A2???	1
AF - Afghanistan, Repubblica islamica di	1
AL - Albania	1
BG - Bulgaria	1
BY - Bielorussia	1
CU - Cuba	1
CY - Cipro	1
EC - Ecuador	1
HK - Hong Kong	1
HR - Croazia	1
HU - Ungheria	1
IQ - Iraq	1
LU - Lussemburgo	1
MC - Monaco	1
MD - Moldavia	1
MT - Malta	1
MY - Malesia	1
NZ - Nuova Zelanda	1
PK - Pakistan	1
SC - Seychelles	1
Totale	10211

Salva come PNG Salva come JPEG

Città	#
Beijing	529
Houston	249
Fairfield	238
Ann Arbor	235
Torino	201
Villeurbanne	196
Dearborn	163
Jacksonville	149
Milan	132
Warsaw	124
Rome	122
Wilmington	102
Woodbridge	101
Pisa	94
Seattle	87
Ashburn	82
Cambridge	75
Vienna	72
Redwood City	68
Dong Ket	60
Napoli	48
Munich	35
Hangzhou	28
Verona	27
Dallas	26
Genova	25
Fremont	24
Palermo	24
Mountain View	22
Düsseldorf	19
Hefei	19
Nanjing	19
Padova	19
Seongnam	18
Toronto	18
Menlo Park	17
Shanghai	16
Bologna	15
Florence	15
Ottawa	15
Duncan	14
Brescia	13
Catania	12
Missaglia	11
Parma	11
San Diego	11
Trieste	11
Bari	10
Kunming	10
Massa	10
Piemonte	10
Seoul	10
Fuzhou	9
Guangzhou	9
Monza	9
Pescara	9
Segrate	9
Venezia	9
Brindisi	8
Como	8
Messina	8
Nanchang	8
Phoenix	8
Buffalo	7
Cagliari	7
Caserta	7
Castelnuovo Rangone	7
Catanzaro	7
Modena	7
Polska	7
Trento	7
Crotone	6
Foggia	6
Lachine	6
Loreto	6
Pasadena	6
Salerno	6
Sassari	6
Silver Spring	6
Vicenza	6
Berlin	5
Capena	5
Cinisello Balsamo	5
Hebei	5
Istanbul	5
La Spezia	5
Montecalvoli	5
Nichelino	5
Pesaro	5
Piacenza	5
Piombino	5
Reggio Nell'emilia	5
Shenyang	5
Terni	5
Torre Del Greco	5
Turin	5
Udine	5
Valencia	5
Varese	5
Vigo	5
Totale	3965

Salva come PNG Salva come JPEG

Nome	#
Somministrazione intravescicale di Mitomicina C in ipertermia nei carcinomi vescicali superficiali a rischio intermedio	2769
L'alcol etilico nei farmaci chemioterapici antiblastici iniettabili: valutazioni ed implicazioni pratiche	1347
Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with Mitomycin C in superficial transitional cell carcinoma patients	273
Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I–II study	272
PEGylation of proteins and liposomes, a powerful and flexible strategy to improve the drug delivery	197
Pharmacokinetic study to optimize the intravesical administration of gemcitabine	193
Antibiotic adjustment in CRRT	175
Farmacocinetica del paclitaxel in associazione con acido valproico nella terapia del tumore anaplastico della tiroide	146
Preparation and characterization of novel poly(ethylene glycol) paclitaxel derivatives.	128
Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial	116
Recent studies on the delivery of hydrophilic drugs in nanoparticulate systems.	115
Chemical and microbiological stability, anticoagulant efficacy and toxicity of 35 and 90 mM trisodium citrate solutions stored in plastic syringes	114
Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody	113
Messa a punto del metodo di estrazione e determinazione analitica, tramite HPLC, dell'amfotericina B su campioni ematici	112
Validation of a simple and economic HPLC-UV method for the simultaneous determination of vancomycin, meropenem, piperacillin and tazobactam in plasma samples	107
Analogs of squalene and oxidosqualene inhibit oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae	107
Vaccini, sieri, immunoglobuline e anticorpi monoclonali	105
A Pharmacokinetics Study to Optimize Intravesical Administration of Gemcitabine	94
Targeted Cancer Therapy: The Roles Played by Antibody-Drug and Antibody-Toxin Conjugates	92
Hyaluronic Acid Conjugates as Vectors for the Active Targeting of Drugs, Genes and Nanocomposites in Cancer Treatment	86
Vinyl sulfide derivatives of truncated oxidosqualene as selective inhibitors of oxidosqualene and squalene-hopene cyclases	75
Lipid nanoparticles as vehicles for oral delivery of insulin and insulin analogs: preliminary ex vivo and in vivo studies	66
Fenil vinil solfuri e metil vinil solfuri, inibitori specifici della ossidosqualene ciclasi di Trypanosoma cruzi e di S. cerevisiae.	62
Vinyl sulfide derivatives of oxidosqualene, as inhibitors of oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae.	59
Farmacocinetica della Gemcitabina (GEM) e del suo trifosfato (dFdCTP) in infusione prolungata a basse dosi in monochemioterapia in pazienti affetti da tumori solidi	58
Alternate scheduling of Gemcitabine (GEM) - Oxaliplatin (OXA) association in metastatic (MTS) or locally advanced (LA) pancreatic adenocarcinoma: a clinical and pharmacokinetic (pk) evaluation	57
Paclitaxel e doxorubicina liposomiale peghilata in tumori testa/collo recidivanti: un’inaspettata interazione farmacocinetica intervallo-dipendente relativa alla somministrazione	56
I medicinali senza obbligo di prescrizione in Pediatria. Tra raccomandazioni e automedicazione	53
polyclonal antibodies against a fragment of oxidosqualene cyclase(erg7p) overexpressed in E.coli recognize the enzyme of different sources	53
Synthesis and biological activity of aryldithio and maleimido squalene derivatives as new irreversible inhibitors of squalene 2,3-oxide-lanosterol cyclase.	52
Farmacocinetica della somministrazione alternata della Gemcitabina (GEM) e Oxaliplatino (OXA) nei tumori pancreatici e delle vie biliari	51
29-methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase.	51
The 3-keto reductase protein (Erg27p) is required for oxidosqualene cyclase (Erg7p) activity in yeast	50
Yeast Oxidosqualene cyclase (Erg7p) Is a Major Component of Lipid Particles. J. Biol. Chem. (2002) 277, 2406-2412.	50
Studio Farmacocinetico per determinare la modalità di somministrazione più idonea per la gemcitabina endovescicale	49
A first pharmacokinetic study of mitomycin C intravesical thermo-chemotherapy for the treatment of superficial transitional cell carcinoma, "Beyond the Abstract," by Paola Milla, et al.	49
Systematic analysis of yeast strains with possible defects in lipid metabolism	49
Thiol-modifying Inhibitors for Understanding Squalene Cyclase Function. Eur. J. Biochem. (2002) 269, 2108-2116.	48
Yeast Oxidosqualene cyclase (Erg7p) Is a Major Component of Lipid Particles	48
PHARMACOKINETICS, PHARMACOLOGICAL STABILITY, SAFETY AND ACTIVITY OF MMC ADMINISTERED WITH A NEW HYPERTHERMIA DEVICE (UNITHERMIA)	47
Studio farmacocinetico del Paclitaxel in associazione con acido valproico nella terapia del tumore anaplastico della tiroide	47
19-azasqualene-2,3-epoxide and its N-oxide: metabolic fate and inhibitory effect on sterol biosynthesis in Saccharomyces cerevisiae	47
A pharmacokinetics study to optimize intravesical administration of gemcitabine	47
Farmacocinetica dell’associazione di vinorelbina orale con doxorubicina liposomiale peghilata nel tumore mammario metastatico	46
Economic evaluation of different modalities of immunoglobulin therapy in chronic dysimmune polyradiculoneuropathies	46
Sterospecific irreversible inhibitors of liver and yeast oxidosqualene cyclase	45
Synthesis of novel 4,5-diphenylthiazole derivatives as potential acyl-CoA: cholesterol O-acyltransferase inhibitors	44
Stereospecific synthesis of trans-vinyl dioxidosqualene and b-hydrosulfide derivatives, as potent and time-dependent 2,3-oxidosqualene cyclase inhibitors	44
Inhibition of sterol biosynthesis in Saccharomyces cerevisiae and Candida albicans by 22,23-epoxy-2-aza-2,3-dihydrosqualene and the corresponding N-oxide.	44
Thiol-modifying agents as tools for understanding the function of squalene cyclase	43
Subcellular localization of yeast oxidosqualene cyclase and other eukaryotic oxidosqualene cyclases expressed in yeast	43
Anti-TNF-α drugs: pharmacoeconomic analysis and proper use in pharmacological treatment in rheumatoid arthritis	43
Pharmacokinetics, Pharmacological Stability, Safety and Efficacy of MMC Administered with a New Hyperthermia Device	43
Yeast oxidosqualene cyclase (Erg7p) is a major component of lipid particles	42
Studio farmacocinetico e tossicologico dell’effetto neuroprotettivo del glutatione ridotto sulla chemioterapia basata sull’oxaliplatino nel carcinoma colon-rettale avanzato	42
Study of sequence-dependent pharmacokinetic interactions between oral vinorelbine (VNR) and pegylated liposomal doxorubicin (PLD) in metastatic ovarian carcinoma	42
Preparation and characterization of novel PEG-paclitaxel derivatives	42
Coagulation Factor VIII: pharmacoeconomic evaluation and quality of life as measuring tools in clinical practice	41
Design of specific tools to evaluate the Cost Of Illness (COI) of Rheumatoid Arthritis	41
Conjugated Methyl Sulfide and phenyl Sulfide Derivatives of Oxidosqualene as Inhibitors of Oxidosqualene and Squalene-Hopene Cyclases.	41
Subcutaneous vs. intravenous immunoglobulin in CIDP: pharmacokinetic and clinical response	40
An independent study about over the counter medicines to analyse parents’ awareness for paediatric use	39
Subcellular localization of oxidosqualene cyclases from Arabidopsis thaliana, Trypanosoma cruzi and Pneumocystis carinii expressed in yeast	39
Stereospecific inhibition of sterol biosynthesis in HEP G2 and Saccharomyces cerevisiae cell cultures by 29-methylidene-oxidosqualene derivatives.	39
The impact of five different administration intervals on the pharmacokinetics (PK) of paclitaxel (PTX) and pegylated liposomal doxorubicin (PLD) combination	38
Topology of DNA: when manipulation supports the lack of “space-filling” imagination	36
PHARMACOKINETICS, PHARMACOLOGICAL STABILITY AND SAFETY OF MMC ADMINISTERED WITH A NEW HYPERTHERMIA DEVICE	36
Administration of reduced glutathione in FOLFOX4 regimen in advanced colorectal cancer: effect on oxaliplatin pharmacokinetics and on Pt-DNA adducts formation	36
The effect of five different administration intervals on the pharmacokinetics (pk) of paclitaxel (PTX) and pegylated liposomal doxorubicin (PLD) association regimen	36
Studio farmacocinetico dell’associazione di vinorelbina (VNR) per via orale con doxorubicina liposomale peghilata (PLD) nel carcinoma mammario metastatico	36
2,3-oxidosqualene cyclase from yeast: a target enzyme for drug discovery.	36
3-carboxy-4-nitrophenyl-dithio-1,1'-2-trisnorsqualene: a site directed inactivator of yeast oxidosqualene cyclase	34
Subcellular distribution and selective inhibition of oxidosqualene cyclases of Trypanosoma cruzi and Pneumocystis carinii expressed in Saccharomyces cerevisiae	34
Medicinali biologici ad alto costo e ad alta spesa nell'artrite reumatoide: tra sostenibilità ed opportunità	34
Sulfide derivatives of oxidosqualene inhibitors of 2,3-oxidosqualene and squalene-hopene cyclase as antifungals or hypocholesterolemics.	34
Association of Gemcitabine (GEM) and Oxaliplatin (OXA) in metastatic or locally advanced pancreatic adenocarcinoma: a clinical and pharmacokinetic (PK) study	33
Herbal Medicines in Children: between advice-giving and self-medication	33
Comparison of the mechanism of yeast oxidosqualene cyclase and bacterial squalene cyclase by using rationally designed inhibitors.	33
Synthesis and in vitro evaluation of new 4,5-diphenylthiazole derivatives as acyl-CoA:cholesterol O-acyl transferase inhibitors	32
Paclitaxel and pegylated liposomal doxorubicin in recurrent head/neck cancer: clinical and pharmacokinetic preliminary data	32
Self-Assembled Squalene-based Fluorescent Heteronanoparticles	32
Effects of the Molecular Weight of Hyaluronic Acid in a Carbon Nanotube Drug Delivery Conjugate	32
Synthesis and biological activity of new iodoacetamide derivatives on mutants of squalene-hopene cyclase	32
Active site titration of bovine beta-trypsin by N alpha-(N,N-dimethylcarbamoyl)-alpha-aza-lysine p-nitrophenyl ester: kinetic and crystallographic analysis	31
Pharmacokinetic (PK) evaluation of 2’,2’-Difluorodeoxycytidine-5’-triphosphate (dFdCTP) and gemcitabine (GEM) as prolonged infusion in monochemotherapy in patients affected by solid tumors	31
Ottimizzazione della somministrazione endovescicale di gemcitabina: uno studio farmacocinetico	31
Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity.	31
Gemcitabine and oxaliplatin in patients with pancreatic adenocarcinoma - Clinical and pharmacokinetic data	30
Adherence to oral chemotherapy: Evidence from a randomised clinical trial	30
Synthesis of (E)- and (Z)-29-methylidyne-2,3-oxidosqualene derivatives as inhibitors of liver and yeast oxidosqualene cyclase	28
Comparative properties of N-ethoxycarbonyl-D-phenylalanyl-L-prolyl-alpha-azalysine p-nitrophenyl ester and N-ethoxycarbonyl-D-phenylalanyl-alpha-azaprolyl-L-lysine p-nitrophenyl ester as subsrates of serine proteinases	28
Radiofarmaci	28
Pharmacokinetic evaluation of gemcitabine and 2',2'-difluorodeoxycytidine-5'-triphosphate after prolonged infusion in patients affected by different solid tumors	28
Paclitaxel and pegylated liposomal doxorubicin in recurrent head and neck cancer: Clinical and unexpected pharmacokinetic interactions	28
Effects of reduced glutathione (GSH) on oxaliplatin (OXA) in advanced colorectal cancer treated by FOLFOX4 regimen: Pharmacokinetics (PK) and determination of PtDNA adducts	27
Mutants of squalene hopene cyclase: synthesis and biological activity of new iodoacetamide derivatives as thiol reactive groups.	27
Effect of proteases on microsomal oxidosqualene cyclases from Saccharomyces cerevisiae and Candida albicans	26
Pharmacoeconomic analysis and the appropriate use of Imatinib Mesylate in the Piedmont region	26
Stereospecific irreversible inhibitors of liver and yeast oxidosqualene cyclase.	26
Human alpha-thrombin inhibition by the highly selective compounds N-ethoxycarbonyl-D-Phe-Pro-alpha-azaLys p-nitrophenyl ester and N-carbobenzoxy-Pro-alpha-azaLys p-nitrophenyl ester: a kinetic, thermodynamic and X-ray crystallographic study	25
Totale	9904

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	10706
article - articoli	0
book - libri	0
conference - conferenze	5487
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	16193

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2016/2017	425	0	0	0	0	0	0	0	0	0	0	355	70
2017/2018	1498	50	138	56	47	44	43	81	222	460	207	75	75
2018/2019	1744	62	79	116	99	145	116	95	208	131	167	320	206
2019/2020	2323	232	188	213	218	173	326	211	124	154	150	172	162
2020/2021	2365	255	139	154	179	270	155	203	127	260	218	172	233
2021/2022	1334	95	97	91	115	137	109	117	136	62	101	274	0
Totale													10706

CINECA IRIS Institutional Research Information System

statistiche per MILLA, Paola